Global Influenza Diagnostics Market to reach USD 2.45 billion by 2032 with 5.69% CAGR
From GlobeNewswire: 2025-03-25 09:20:00
The global Influenza Diagnostics Market was valued at USD 1.49 billion in 2023, projected to reach USD 2.45 billion by 2032 with a CAGR of 5.69%. The US accounted for an 11% share in 2023 due to its advanced healthcare infrastructure. Seasonal influenza causes 3 to 5 million severe cases yearly, driving market growth.
Major players in the market include 3M, Abbott Laboratories, and Becton, Dickinson and Company. The market size is expected to grow to USD 2.45 billion by 2032 with a CAGR of 5.69% from 2024 to 2032. Key regions covered include North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
Test kits and reagents led the market in 2023 with a 61% share, as they are essential for analyzing influenza viruses. Traditional flu testing diagnostics held 65% of the market share in 2023, with rapid immunodiagnostic tests gaining popularity. Hospitals and clinics contributed the largest share of revenue in 2023, emphasizing the importance of early diagnosis and treatment. The influenza diagnostics market is seeing rapid advancements in point-of-care testing, leading to faster decision-making and better patient outcomes. Key segments include products like test kits and instruments, end-users like hospitals and clinics, and various types of tests from traditional to molecular. North America leads in revenue, with the US reporting 35 million flu cases in 2022-2023.
Europe and Asia-Pacific also play significant roles in the market, with Germany, France, and the UK leading in advanced testing technologies. Recent developments include Abbott Laboratories’ new rapid molecular test and Roche Diagnostics’ FDA-approved cobas Liat System. The market is expected to grow, driven by increasing healthcare investments and awareness about influenza prevention.
To access detailed insights and analysis of the influenza diagnostics market, interested parties can purchase a single-user PDF report from SNS Insider. The report covers key points like market dynamics, statistical insights, competitive landscape, regional analysis, company profiles, and more. SNS Insider aims to provide clients with up-to-date market data and insights to make informed decisions in a rapidly changing environment.
Read more at GlobeNewswire: Influenza Diagnostics Market Size to Hit USD 2.45 Billion
